Scott Williams

7PUBLICATIONS
75CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsEpidemiological methodsPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 24, 2026
ENZARAD (ANZUP 1303): Phase 3 Trial of Enzalutamide With Androgen Deprivation Therapy and Radiation Therapy in High-Risk Localized or Locally Advanced Prostate Cancer.

|Feb 06, 2026
Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Aslı D Munzur, Cameron Herberts, Edmond M Kwan

|Aug 21, 2023
The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy.

Matthew J Roberts, Ciara Conduit, Ian D Davis

|Aug 26, 2022
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.

Javier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia

|Dec 20, 2021
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.

Martin R Stockler, Andrew J Martin, Ian D Davis

|Sep 01, 2020
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting.

Andrea K Miyahira, Kenneth J Pienta, John W Babich

Pageof 2

Frequent Collaborators

4 joint publications

Ian D Davis

3 joint publications

Martin Stockler

3 joint publications

Michael S Hofman

3 joint publications

Christopher Sweeney